Non-vascular Stents Market Size, Share & Trends Analysis Report By Type (Gastrointestinal Stents, Duodenal, Colonic, Pulmonary (Airway) Stents, Urological Stents), By End Use (Hospitals), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED: September 18, 2024

PAGES: 100 Pages

DELIVERY TIME: 2-10 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Non-vascular Stents Market Growth & Trends:

The global non-vascular stents market size is expected to reach USD 2.27 billion by 2030, registering a CAGR of 4.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth during the forecast period due to technological advancements in the non-vascular stents and rise in the adoption of minimally invasive surgeries across the world.

Technological advancements such as the development of radioactive & biodegradable stents, advanced stent designs & change in material composition, and newer stent placement techniques, such as Endoscopic Ultrasound-guided (EUS) stenting, are expected to help in the growth of the non-vascular stents market over the forecast period. Various materials such as metallic stents, made from alloys include nitinol, silicone & nitinol, stainless steel, and elgiloy (cobalt-chromium-nickel Alloy) and nonmetallic stents, made from synthetic polymers such as resins, polyurethane, and silicone, are used as per the requirement as they offer different features.

Due to the high adoption of minimally invasive techniques, such as nonvascular stenting, by healthcare professionals, the market is expected to grow. This can be attributed to the various advantages such as smaller incisions, rapid wound healing, and reduced pain & surgical scars. Smaller incisions and surgical wounds result in lesser complications, which significantly reduces the overall surgery cost. Moreover, minimally invasive surgeries result in reduced hospital stay, which ultimately lowers the risk of hospital-acquired infections in patients. This helps reduce the overall healthcare expenditure of patients.

Non-vascular Stents Market Report Highlights:

Biliary stents dominated the market in 2023 due to increasing occurrence of liver and bile duct diseases such as cholangiocarcinoma and gallstones resulting in a rising need for less invasive methods to deal with blockages.
The gastrointestinal stents segment is expected to register the highest growth over the forecast period owing to surge in the number of cases of gastrointestinal cancer, such as cancer of the esophagus, stomach, gallbladder, small intestine, pancreas, liver, bowel, and anus
North America is expected to dominate the market during the forecast period owing to the local presence of major market players and robust healthcare infrastructure coupled with a high prevalence of gastrointestinal cancer in the U.S. & Canada.

Product Code: GVR-1-68038-663-9

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Global Non-Vascular Stents Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Global Non-Vascular Stents Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Global Non-Vascular Stents Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Non-Vascular Stents Market: Product Movement Analysis, 2023 & 2030 (USD Billion)
4.3. Gastrointestinal Stents
- 4.3.1. Gastrointestinal Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Biliary
- 4.4.1. Biliary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.5. Duodenal
- 4.5.1. Duodenal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6. Colonic
- 4.6.1. Colonic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7. Pancreatic
- 4.7.1. Pancreatic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.8. Esophageal Stents
- 4.8.1. Esophageal Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.9. Pulmonary (Airway) Stents
- 4.9.1. Pulmonary (Airway) Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.10. Silicone Airway
- 4.10.1. Silicone Airway Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.11. Metallic Airway
- 4.11.1. Metallic Airway Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.12. Urological Stents
- 4.12.1. Urological Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Globe Non-Vascular Stents Market: End Use Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Non-Vascular Stents Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
5.3. Hospitals
- 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.4. Ambulatory Care Centers (ACS)
- 5.4.1. Ambulatory Care Centers (ACS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.5. Specialty Clinics
- 5.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Globe Non-Vascular Stents Market: Regional Estimates & Trend Analysis

6.1. Non-Vascular Stents Market Share, By Region, 2023 & 2030, USD Billion
6.2. North America
- 6.2.1. North America Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.2.2. U.S.
  - 6.2.2.1. U.S. Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.2.3. Canada
  - 6.2.3.1. Canada Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.2.4. Mexico
  - 6.2.4.1. Mexico Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3. Europe
- 6.3.1. Europe Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.3.2. U.K.
  - 6.3.2.1. U.K. Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.3.3. Germany
  - 6.3.3.1. Germany Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.3.4. Italy
  - 6.3.4.1. Italy Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.3.5. Spain
  - 6.3.5.1. Spain Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.3.6. Denmark
  - 6.3.6.1. Denmark Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.3.7. Sweden
  - 6.3.7.1. Sweden Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.3.8. Norway
  - 6.3.8.1. Norway Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4. Asia Pacific
- 6.4.1. Asia Pacific Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4.2. China
  - 6.4.2.1. China Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4.3. Japan
  - 6.4.3.1. Japan Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4.4. India
  - 6.4.4.1. India Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4.5. South Korea
  - 6.4.5.1. South Korea Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4.6. Australia
  - 6.4.6.1. Australia Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4.7. Thailand
  - 6.4.7.1. Thailand Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5. Latin America
- 6.5.1. Latin America Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.5.2. Brazil
  - 6.5.2.1. Brazil Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.5.3. Argentina
  - 6.5.3.1. Argentina Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6. Middle East and Africa
- 6.6.1. Middle East and Africa Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.6.2. Saudi Arabia
  - 6.6.2.1. Saudi Arabia Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.6.3. UAE
  - 6.6.3.1. UAE Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.6.4. South Africa
  - 6.6.4.1. South Africa Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.6.5. Kuwait
  - 6.6.5.1. Kuwait Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
- 7.4.1. Medtronic
  - 7.4.1.1. Participant's Overview
  - 7.4.1.2. Financial Performance
  - 7.4.1.3. Product Benchmarking
  - 7.4.1.4. Recent Developments/ Strategic Initiatives
- 7.4.2. BD
  - 7.4.2.1. Participant's Overview
  - 7.4.2.2. Financial Performance
  - 7.4.2.3. Product Benchmarking
  - 7.4.2.4. Recent Developments/ Strategic Initiatives
- 7.4.3. Boston Scientific Corporation
  - 7.4.3.1. Participant's Overview
  - 7.4.3.2. Financial Performance
  - 7.4.3.3. Product Benchmarking
  - 7.4.3.4. Recent Developments/ Strategic Initiatives
- 7.4.4. ELLA - CS, s.r.o.
  - 7.4.4.1. Participant's Overview
  - 7.4.4.2. Financial Performance
  - 7.4.4.3. Product Benchmarking
  - 7.4.4.4. Recent Developments/ Strategic Initiatives
- 7.4.5. CONMED Corporation
  - 7.4.5.1. Participant's Overview
  - 7.4.5.2. Financial Performance
  - 7.4.5.3. Product Benchmarking
  - 7.4.5.4. Recent Developments/ Strategic Initiatives
- 7.4.6. HOBBS MEDICAL, INC
  - 7.4.6.1. Participant's Overview
  - 7.4.6.2. Financial Performance
  - 7.4.6.3. Product Benchmarking
  - 7.4.6.4. Recent Developments/ Strategic Initiatives
- 7.4.7. Cook
  - 7.4.7.1. Participant's Overview
  - 7.4.7.2. Financial Performance
  - 7.4.7.3. Product Benchmarking
  - 7.4.7.4. Recent Developments/ Strategic Initiatives
- 7.4.8. TAEWOONG
  - 7.4.8.1. Participant's Overview
  - 7.4.8.2. Financial Performance
  - 7.4.8.3. Product Benchmarking
  - 7.4.8.4. Recent Developments/ Strategic Initiatives
- 7.4.9. Glaukos Corporation
  - 7.4.9.1. Participant's Overview
  - 7.4.9.2. Financial Performance
  - 7.4.9.3. Product Benchmarking
  - 7.4.9.4. Recent Developments/ Strategic Initiatives